Skip to main content
Cancer Explained
Donate
Beginner 6 min readEditorial review complete

What Does BI-RADS 3 Mean?

BI-RADS 3: what it usually means, what it does not prove, and what to ask next.

Source

RadiologyInfo - Breast Imaging Report

A female doctor and male doctor review scans together on monitors
A female doctor and male doctor review scans together on monitors

Key fact

BI-RADS 3 has a specific meaning in breast imaging reports.

The short answer

BI-RADS 3 is report language that needs context. In breast imaging reports, it usually means probably benign, with a small chance of cancer, so short-interval follow-up is commonly discussed. This page explains the plain-language meaning, limits, likely next questions, and why your care team must interpret it with the rest of your results.

  • BI-RADS 3 has a specific meaning in breast imaging reports.

  • The phrase alone is not the whole diagnosis or treatment plan.

  • The next step depends on the full report, prior tests, symptoms, and your cancer history.

  • Ask what the finding changes, what remains uncertain, and when you will review the plan.

Choose how you want to understand this

The full explanation.

The number is a probability, not a description

BI-RADS stands for Breast Imaging Reporting and Data System. It is a scale from 0 to 6 that radiologists use to convert what they saw into a single number, so that every reader of the report understands the same thing.

Category 3 means probably benign. RadiologyInfo describes it as probably negative, with a small chance of cancer, usually stated as two percent. StatPearls puts it as a risk of malignancy below 2 percent, with shortened-interval follow-up to confirm the finding is stable.

So a 3 is not a diagnosis and not a biopsy recommendation. It is the radiologist saying: this almost certainly is not cancer, and I want to prove it by watching rather than by cutting.

The whole scale, so you can see where 3 sits

NCI lists each category with the cancer risk within one year.

  • 0 — Incomplete. More imaging or older films are needed before a number can be given.
  • 1 — Negative. About 1 percent risk within a year.
  • 2 — Benign findings, such as a simple cyst. About 1 percent.
  • 3 — Probably benign. About 2 percent.
  • 4 — Suspicious, spanning 2 to 95 percent, split into 4a at 2 to 10 percent, 4b at 10 to 50 percent, and 4c at 50 to 95 percent.
  • 5 — Highly suggestive of malignancy. About 95 percent.
  • 6 — Cancer already proven by biopsy.

Look at the jump from 3 to 4a. It is small. Two percent versus a range starting at two percent. The practical difference is what happens next: a 3 gets watched, a 4 gets a needle. Radiologists reserve category 3 for findings that meet specific criteria, and when a finding does not clearly fit, it moves up.

Worth noting a small difference in how the sources put it. StatPearls describes the scale as running from essentially zero to greater than 95 percent, while NCI's screening summary assigns about 1 percent risk within one year to categories 1 and 2. A clean mammogram lowers the odds; it does not zero them.

What federal law actually requires

Mammography reporting in the United States is regulated, which is unusual among imaging tests. Under 21 CFR 900.12, a facility must place each mammogram into a named assessment category. The regulation's wording for this one is short: "Probably Benign" means the finding has a high probability of being benign.

The timing rules matter more than people realize.

  • Results must reach you within 30 days of the exam.
  • If the assessment is Suspicious or Highly Suggestive of Malignancy, the facility has 7 calendar days to notify you and your referring provider.

Read that again if you are waiting on a letter. A BI-RADS 3 does not trigger the 7-day clock. A slow letter after a BI-RADS 3 is what the rule allows, not a sign that something was found.

Two percent of what, exactly

Context helps here, because two percent sounds different depending on what you compare it to.

NCI reports that about 10 percent of women screened in the United States get called back for more evaluation. Only about 0.5 percent of women screened actually have cancer. That leaves roughly 9.5 percent of screened women with a false-positive result.

Stretch that across time and it compounds. Over ten years of annual mammograms, about half of women get at least one false positive. Between 7 and 17 percent of those women end up having a biopsy for a finding that was not cancer.

Category 3 exists to shrink that last number. It is a deliberate choice to avoid a biopsy in a group where 98 out of 100 findings will turn out to be nothing.

Why six months, and not twelve

RadiologyInfo describes the standard next step as a follow-up scan in six months.

The interval is doing specific work. Six months is long enough that a growing cancer would show measurable change, and short enough that a cancer that did grow has not had time to spread far. It is a stability test, not a repeat of the original question.

Two practical implications follow. First, keep the appointment. The whole value of a category 3 depends on the follow-up happening on schedule, and a missed six-month scan converts a careful plan into no plan. Second, ask that the follow-up be done at the same facility, or that the prior images be sent there. NCI notes that having prior mammograms available for comparison reduces false positives.

Category 0 is not category 3

One thing to check on your own report. NCI defines category 0 as incomplete, meaning more evaluation or older mammograms are needed.

A finding usually earns a 3 after a full diagnostic workup, with extra mammogram views or an ultrasound. If your report went from a routine screening straight to a 3 with no additional imaging in between, ask whether the workup was completed or whether the radiologist was still waiting on prior films.

The density sentence is separate

Your report also carries a breast density statement, and it has nothing to do with your BI-RADS number.

RadiologyInfo lists four density levels: almost entirely fatty, scattered areas of fibroglandular density, heterogeneously dense, and extremely dense. FDA requires the lay-language summary to say one of two things. Either that your breast tissue is not dense, or that your breast tissue is dense and that in some people with dense tissue, other imaging tests in addition to a mammogram may help find cancers.

Dense tissue does not raise your BI-RADS category. It changes how well the mammogram can see, which is a different problem.

Ask these before you leave

  • Was this a screening study or a completed diagnostic workup with extra views or ultrasound?
  • What exactly is the finding: a mass, an asymmetry, calcifications, or something seen only on ultrasound?
  • Were prior mammograms available for comparison, and if not, can they be obtained?
  • What date is the six-month follow-up, and is it already scheduled?
  • What change on the next scan would move this to a category 4 and a biopsy?
  • Is the follow-up covered as a diagnostic study, and what will it cost me?
  • Does anything about my personal or family history change how a category 3 should be handled?

See Imaging Tests, Pathology Reports, and Getting a Second Opinion.

Sources

Words to know

Tap any term to see what it means.

Browse the full glossary →

A woman sits in a chair talking with a clinician in an exam room

Common questions

What does BI-RADS 3 mean?

In general, BI-RADS 3 usually means probably benign, with a small chance of cancer, so short-interval follow-up is commonly discussed.

Does it mean cancer?

It is not the same as a cancer diagnosis and usually is not the same as a biopsy recommendation.

What should I ask next?

A practical next question is to ask what follow-up schedule is recommended, whether older images were compared, and what change would trigger biopsy.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Look up related pathology, imaging, biomarker, and treatment-response language.

Decode another report term
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Knowledge Check

0 of 3 answered

  1. Q1.What is the safest way to interpret BI-RADS 3?
  2. Q2.What is a useful next question?
  3. Q3.Why might older records matter?

This self-assessment checks understanding of educational content only. It is not medical advice.

Prepared by Cancer Explained's AI-assisted editorial system

Written from RadiologyInfo - Breast Imaging Report material and checked line by line against the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-07-20 what this meansLast updated: 2026-08-17Next planned review: 2027-07-20

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Still have questions?

Educational answers, plain language

Ask Cancer Explained

Doctor Visit Prep Tool

Get a personalized list of questions to ask about this topic.

Start the guide

Related learning map

How this explanation connects to 10 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Does BI-RADS 3 Mean?